LI Y Z, TENG D, SHI X G, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020, 369: m997.
[3]
LI X L, ZHANG Q X, WANG X W, et al. Analysis and explanation of medication errors big data in Chinese Medical Institutions[J]. Chin J Pharmacoepidemiol(药物流行病学杂志), 2017, 26(1):40-45.
[4]
INSTITUTE FOR SAFE MEDICATION PRACTICES. Guidelines for optimizing safe subcutaneous insulin use in adults[EB/OL]. [2017-05-15]. https://www.ismp.org/sites/default/files/attachments/2017-11/ISMP138-Insulin%20Guideline-051517-2-WEB.pdf.
[5]
YANG T, GUO L X, WENG J P, et al. Guidelines for insulin treatment of Type 1 diabetes mellitus in China[J]. Chin J Diabetes(中华糖尿病杂志), 2016, 8(10):591-597.
[6]
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Type 1 diabetes in adults: diagnosis and management [EB/OL]. [2016-07-15]. https://www.nice.org.uk/guidance/ng17.
[7]
AMERICAN DIABETES ASSOCIATION. Standards of medical care in diabetes-2020[EB/OL]. [2020-01-01]. https://care.diabetesjournals. org/content/43/Supplement_1.
[8]
COMMITTEE ON PRACTICE BULLETINS-OBSTETRICS. Practice bulletin No. 180: gestational diabetes mellitus [J]. Obstet Gynecol, 2017,130(1):e17-e37.
[9]
CHINESE SOCIETY OF OBSTETRICS AND GYNECOLOGY, CHINESE SOCIETY OF PERINATAL MEDICINE. Draft guidelines for diagnosis and treatment on pregnancy and diabetes[J]. Chin J Obstet Gynecol(中华妇产科杂志), 2014, 49(8):561-569.
[10]
GARBER A J, ABRAHAMSON M J, BARZILAY J I, et al. Consensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm-2019 executive summary[J]. Endocrine Practice, 2019, 25(1):69-100.
[11]
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Type 2 diabetes in adults: management[EB/OL]. [2020-12-16]. https://www.nice.org.uk/guidance/ng28.
[12]
THE STATE COUNCIL. State council urges improving national system for essential drugs[EB/OL]. [2018-09-19]. http://www.gov.cn/zhengce/content/2018-09/19/content_5323459.htm?from=groupmessage&isappinstalled=0.
[13]
NATIONAL HEALTH COMMISSION OF THE PEOPLE′S REPUBLIC OF CHINA. Notice on further strengthening the management of the provision and use of essential medicines in public medical institutions[EB/OL]. [2019-01-17]. http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=b3f6fb3f55314a7faff97386908bd4f4.
[14]
NATIONAL HEALTH COMMISSION OF THE PEOPLE′S REPUBLIC OF CHINA. Notice of the general office of the national health commission on further doing a good job in the preparation and use of drugs selected in the centralized procurement of drugs organized by the state[EB/OL]. [2019-12-19]. http://www.nhc.gov.cn/yzygj/s7659/201912/7b1639fb14ca4cd59cd33f367455d92d.shtml.
[15]
NATIONAL HEALTH COMMISSION OF THE PEOPLE′S REPUBLIC OF CHINA, MINISTRY OF EDUCATION OF THE PEOPLE′S REPUBLIC OF CHINA, MINISTRY OF FINANCEOF THE PEOPLE′S REPUBLIC OF CHINA, et al. Notice on issuing opinions on strengthening the administration of pharmaceutical affairs in medical institutions and promoting rational use of medicines[EB/OL]. [2020-02-26]. http://www.nhc.gov.cn/yzygj/s7659/202002/ea3b96d1ac094c47a1fc39cf00f3960e.shtml.
[16]
MEDICATION SAFETY PANEL IN CHINA COR GROUP OF INTERNATIONAL NETWORK FOR THE RATIONAL USEOF DRUGS(INRUD), CHINESE PHARMACOLOGICAL SOCIETY PROFESSIONAL COMMITTEE OF DRUG INDUCED DISEASES, CHINESE PHARMACEUTICAL ASSOCIATION PROFESSIONAL COMMITTEE OF HOSPITAL PHARMACY, et al. Guideline for prevention of medication errors of high-alertmedications[J]. Advers Drub React J(药物不良反应杂志), 2017, 19(6):403-408.
[17]
JOINT COMMISSION INTERNATIONAL. Hospital evaluation criteria (6th Ed)[R]. Beijing:Peking Union Medical College Press, 2017.
[18]
CHINESE PHARMACEUTICAL ASSOCIATION PROFESSIONAL COMMITTEE OF HOSPITAL PHARMCAY. Recommendedcatalogue of high-alertmedications in China (2019 Edition)[EB/OL]. [2019-05-27]. http://www.psmchina.cn/psm/specialtopic/jsyp/jsyp.html.
[19]
WORLD HEALTH ORGANIZATION. Medication safety in high-risk situations[EB/OL]. [2019-10-31]. https://apps.who.int/iris/handle/10665/325131.
[20]
NATIONAL HEALTH COMMISSION OF THE PEOPLE′S REPUBLIC OF CHINA, THE STATE ADMINISTRATION OF TRADITIONAL CHINESE MEDICINE. Circular of issuing the management standard of audit prescription for medical institutions[EB/OL]. [2018-06-29]. http://www.nhfpc. gov.cn/yzygj/s7659/201807/de5c7c9116b547af819f825b53741173.shtml.
[21]
CHINESE PHARMACEUTICAL ASSOCIATION PROFESSIONAL COMMITTEE OF HOSPITAL PHARMACY. Medical institution pharmaceutical service practices[J]. Her Med(医药导报), 2019, 38(12):1535-1556.
[22]
NATIONAL HEALTH AND FAMILY PLANNING COMMISSION OF THE PEOPLE′S REPUBLIC OF CHINA. Prescription administrative policy[EB/OL]. [2007-02-14]. http://www.nhc.gov.cn/fzs/s3576/201808/d71d4735f6c842158d2757fbaa553b80.shtml.
[23]
SONG F, DONG D, ZHEN JC, et al. Risk management of insulin and its analogues in the prevention of medication errors[J]. Chin J Hosp Pharm(中国医院药学杂志), 2017, 37(7):650-665.
[24]
BAHENDEKA S, KAUSHIK R, SWAI A B, et al. EADSG guidelines: insulin storage and optimisation of injection technique in diabetes management[J]. Diabetes Ther, 2019, 10(2):341-366.
[25]
CHINESE DIABETES SOCIETY. Education and management standards for insulin use in China′s diabetic patients(中国糖尿病患者胰岛素使用教育管理规范)[M]. Tianjin:Tianjin Science and Technology Press, 2011.
[26]
HIGH-ALERT MEDICATION MANAGEMENT COMMITTEE OF CHINESE MEDICAL EDUCATION ASSOIATION, CHINESE PHARMACEUTICAL ASSOCIATION PROFESSIONAL COMMITTEE OF HOSPITAL PHARMACY, CHINESE PHARMACOLOGICAL SOCIETY PROFESSIONAL COMMITTEE OF DRUG INDUCED DISEASES. Experts consensus on clinical application and management of high-alert medication in China (2017 Edition)[J]. Advers Drug React J(药物不良反应杂志), 2017, 19(6): 409-413.
[27]
NATIONAL HEALTH AND FAMILY PLANNING COMMISSION OF THEPEOPLE′S REPUBLIC OF CHINA. Notice on printing and distributing the quality management standards for centralized dispensation of intravenousmedicines[EB/OL]. [2010-4-23]. http://www.nhc.gov.cn/cmssearch/xxgk/getManuscriptXxgk.htm?id=46963.
[28]
ZHANG L J, QIU F, WANG H M, et al. Safety period of multidose parenteral medication: a systematic review[J]. Chin J Hosp Pharm(中国医院药学杂志), 2015, 35(6):510-517.
[29]
CHINESE DIABETES SOCIETY. Expert consensus on self management prescriptions for type 2 diabetes in China (2017 Edition)[J]. Chin J Diabetes(中华糖尿病杂志), 2017, 9(12):740-750.
[30]
CHINESE DIABETES SOCIETY. Clinical application guidelines for glucose monitoring in China (2015 Edition)[J]. Chin J Diabetes(中华糖尿病杂志), 2015, 7(10):603-613.
[31]
CHINESE DIABETES SOCIETY. Guidelines for prevention and treatment of type 2 diabetes in China (2017 Edition)[J]. Chin J Diabetes(中华糖尿病杂志), 2018, 10(1):4-10.
[32]
JI L N, GUO X H, HUANG J, et al. Chinese diabetes drug injection technology guide (2016 Edition)[J]. Chin J Diabetes(中华糖尿病杂志), 2017, 9(2):79-105.
[33]
BECK J, GREENWOOD D A, BLANTON L, et al. 2017 National Standards for diabetes self-management education and support[J]. Diabetes Educ, 2020, 46(1):46-61.
[34]
NATIONAL INSTITUTES OF HEALTH. Managing Diabetes[EB/OL]. [2018-08-30]. https://www.niddk.nih.gov/health-information/diabetes/overview/managing-diabetes.
[35]
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES. Managing diabetes[EB/OL]. [2016-12]. https://www.niddk.nih.gov/health-information/diabetes/overview/managing-diabetes.
[36]
CHINESE DIABETES SOCIETY. Guidelines for diabetes care and education in China[EB/OL]. [2010-07-08]. http://www.diab.net.cn/UploadFile/Ueditor/file/20160811/6360650900034000003924937.pdf.
[37]
CIPOLLE R J, STRAND L M, MORLEY P C. Pharmaceutical care practice: the patient-centered approach to medication management services [M]. 3th Ed BeiJing:Chemical Industry Press, 2017.
[38]
Information Regarding Insulin Storage and Switching Between Products in an Emergency[EB/OL]. [2020-12-26]. https://www.fda.gov/drugs/emergency-preparedness-drugs/information-regarding-insulin-storage-and-switching-between-products-emergency.
[39]
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES. Managing diabetes[EB/OL]. [2016-12]. https://www.niddk.nih.gov/health-information/diabetes/overview/managing-diabetes.
2022, Vol. 57 
